Role of packaging material on Pharmaceutical product stability
What is packaging ?
Packaging is defined as the collection
of different components which surround
the pharmaceutical product from the time
of production until its use
Importance of packaging
• Protect against all adverse external influences
that can alter the properties of the product.
• Protect against biological contamination.
• Protect against physical damage.
• Carry the correct information and identification
of the product.
• Tamper evident / Child ....etc

[:=Read Full Message Here=:]

Organometallic Complexes
organometallic is the compounds which are having at least one direct metal-carbon bond. The metal can be main group, transition or f-group metal, also include boron, silicon, germanium, arsenic, antimony, selenium, and tellurium. The carbon-containing group(s) may be a carbonyl, alkyl, alkene, alkyne, aromatic, cyclic, or heterocyclic compound.
* The field of organometallic Pharmaceuticals dates back to the end of the 1970, Kopf and Kopf-Maier investigated the antitumor activity of early tr ....etc

[:=Read Full Message Here=:]

Hi, I'm Peter. I would like to get full siwes report on mechanical engineering. ....etc

[:=Read Full Message Here=:]

Transformation of family owned tea company business to third largest tea company in the country
1. Overview
The case offers fresh insight into how a simple philosophy of harmony b/w two diff sets of values can be a driving force for the growth and success of a family business. The case explores how changing times called for better measures of management, and proper organisational diversification to survive the market. The HR initiatives of the company are seen with great success as they reflect the strong vis ....etc

[:=Read Full Message Here=:]

I want to write my swies report on pharmaceutical company because that is the place I didn't my industrial training ....etc

[:=Read Full Message Here=:]

RegentAtlantic Capital, LLC
Michael Steiner is a Wealth Manager and Principal with RegentAtlantic Capital, LLC, and
head of the fi rm’s Pharmaceutical Executive Services Group (PESG). David H. Bugen is a
Wealth Manager and Principal, and Brian Kazanchy is a Wealth Manager. William T. Knox IV
is a Wealth Manager and Principal. Margaret V. Prentice is the Chief Marketing Offi cer and
Principal, and Lauren S. Goldfarb is the Business Development Coordinator.
Fiduciary Network, LLC
Mark P. Hurley is President and CEO of Fiduc ....etc

[:=Read Full Message Here=:]

ABSTRACT
The trend among pharmaceutical companies to develop selective drugs of high potency
has pushed the industry to consider the potential of each hazardous ingredient to become
airborne.Dustiness issues are not unique to the pharmaceutical industry, but are relevant
to any industry where powdered materials are mixed, transferred and handled. Interest in
dustiness is also driven by concerns for worker health, the potential for plant explosions
and the prevention of product loss. Unlike other industries, the ....etc

[:=Read Full Message Here=:]

siwes report in radio stations i t department ....etc

[:=Read Full Message Here=:]

....etc

[:=Read Full Message Here=:]

Project Title: Development of a comprehensive Clinical Trials Management System (CTMS) for a pharmaceutical research organization
Background
Clinical trials are done to see if a new drug or device is safe and effective for people to use. Clinical trials are also done for other reasons such as comparing existing treatments to determine the better one. The current, approved treatments are called the standard treatments. Sometimes clinical trials are used to study different ways to use the standard treatments so they will ....etc

[:=Read Full Message Here=:]